Stock TVTX TRAVERE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Travere Therapeutics, Inc.

Equities

TVTX

US89422G1076

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
5.45 USD -5.05% Intraday chart for Travere Therapeutics, Inc. -9.02% -39.38%
Apr. 24 EU Grants Conditional Marketing Approval for CSL Vifor, Travere’s Kidney Disease Treatment MT
Apr. 24 Travere Therapeutics Says Berger's Disease Treatment Granted EU Conditional Marketing Authorization MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. TVTX Stock
  4. Revisions Travere Therapeutics, Inc.